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Abstract: Ricin is a highly toxic type II ribosome-inactivating protein that has potential as 
a biochemical weapon and as the toxic component of immunotoxins. The unfolded protein 
response  (UPR)  is  a  survival  response  that  helps  cells  to  recover  from  endoplasmic 
reticulum  (ER)  stress.  Failure  to  recover  from  ER  stress  leads  to  apoptosis.  In  yeast,  
ricin-A-chain (RTA), the enzymatic component of ricin, inhibits UPR. Our goals were to 
determine  if  RTA  inhibits  UPR  in  two  epithelial  cell  lines  and  if  this  affects  RTA 
cytotoxicity.  RTA  alone  did  not  induce  UPR.  However,  RTA  inhibited  both 
phosphorylation  of  inositol-requiring  enzyme  1  (IRE1)  and  splicing  of  X-box  binding 
protein1 mRNA by the UPR-inducing agent tunicamycin (Tm). The ability of dithiothreitol 
(DTT) to activate eukaryotic translation initiation factor 2 alpha (eIF2α), a component of 
the PERK pathway, was also inhibited by RTA. Treatment with RTA in combination with 
Tm or DTT inhibited protein synthesis more than either agent did alone in one cell line, 
while  caspase  cleavage  was  enhanced  by  the  treatment  combination  in  both  cell  lines. 
These data indicate that RTA is more cytotoxic when UPR is inhibited. This ability to 
inhibit  UPR  may  enhance  the  potential  of  RTA  as  a  therapeutic  immunotoxin  in  
solid tumors. 
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1. Introduction 
Ricin is a glycosylated type II ribosome-inactivating protein (RIP) of 64 kDa that is produced by the 
castor bean plant Ricinus communis. Due to its ease of isolation and extreme toxicity it has been 
classified by the Centers for Disease Control and Prevention as a category B select agent [1]. There is 
also interest in using ricin as the toxic component of immunotoxins to target cancer cells [2,3]. Ricin is 
composed  of  an  enzymatic  A-chain  (RTA)  and  a  B-chain  (RTB)  that  binds  to  exposed  galactose 
residues to facilitate uptake by the cell [4]. After entry, ricin undergoes retrograde trafficking to the 
endoplasmic reticulum (ER), where the disulfide bond between the two subunits is reductively cleaved 
to release RTA [5,6]. RTA interacts with negatively-charged ER membrane lipids that cause its partial 
unfolding  [7]  followed  by  subsequent  transport  to  the  cytosol  by  the  ER-associated  degradation 
(ERAD) pathway that may include interaction with Sec61p, ER degradation enhancing α-mannosidase 
I-like protein (EDEM) and the Hrd1p ubiquitin ligase complex [8–10]. In the cytosol, RTA refolds to a 
catalytically  active  form  with  the  assistance  of  Hsc70  [11].  The  N-glycosidase  activity  of  RTA 
depurinates  a  specific  adenine  in  the  sarcin-ricin  loop  of  the  28S  ribosomal  RNA  subunit  that  is 
essential  for  binding  of  translation  elongation  factors  [12,13],  resulting  in  inhibition  of  protein 
synthesis [14]. 
The ability of type II RIPs, including ricin, to inhibit protein synthesis has been proposed since the 
1980s as a major mechanism that underlies their cytotoxicity. However, recent studies have suggested 
that  inhibition  of  protein  synthesis  may  not  be  sufficient  for  RIPs  or  ribotoxins  to  induce  cell  
death [15,16]. ER stress is induced by conditions that disrupt the normal ER environment. Since many 
type II RIPs traffic through the ER, there is interest in determining if ER stress can contribute to their 
cytotoxicity. ER stress induces the unfolded protein response (UPR), a prosurvival response that serves 
to  restore  ER  homeostasis  during  ER  stress  [17,18].  The  UPR  increases  transcription  of  
ER-localized chaperones and folding enzymes to accelerate the efficiency of protein folding, while 
general protein translation is inhibited to relieve protein accumulation in the ER lumen. In addition, 
phospholipid  synthesis  increases  to  expand  the  capacity  of  the  ER  while  misfolded  proteins  are 
retrotranslocated  to  the  proteosome  for  degradation.  However,  if  the  stress  is  prolonged  or  these 
adaptations fail, apoptotic cell death ensues [19]. 
In  mammalian  cells,  UPR  represents  a  complex  signaling  network  that  involves  three  ER 
transmembrane proteins: IRE1, PERK and ATF6. Under unstressed conditions, the chaperone protein 
BiP (i.e., Grp78) binds to the luminal domains of these sensors, preventing aggregation. However, 
during ER stress BiP binds to unfolded proteins, releasing IRE1, PERK and ATF6, which leads to 
initiation of the UPR [20]. Upon release from BiP, IRE1 homodimerizes and trans-autophosphorylates 
to  activate  its  RNase  activity,  which  cleaves  a  26  nucleotide  intron  from  the  bZIP-containing 
transcription factor X-box binding protein (XBP1) to generate a transcriptional activator of a wide 
array of UPR target genes [17]. PERK also dimerizes and autophosphorylates its kinase domain upon Toxins 2011, 3                         
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release from BiP, followed by activation of eukaryotic initiation factor 2α (eIF2α), leading to global 
inhibition of translation and a decreased protein load on the ER [21]. ATF6 translocates to the Golgi 
apparatus where it is processed by site 1 and site 2 proteases into an active transcription factor that 
regulates expression of genes involved in ER quality control. Both ricin and shiga toxin have been 
shown to induce one or more of these branches of the UPR in mammalian cells [22,23]. In contrast, 
RTA expression in yeast does not induce UPR, but inhibits the UPR elicited by the UPR-inducing 
agents tunicamycin (Tm) and dithiothreitol (DTT) [24]. The ability of RTA to inhibit the UPR was 
suggested to contribute to the cytotoxicity of ricin in yeast [24]. The purpose of the present study was 
to determine if the UPR plays a role in RTA-induced cytotoxicity in mammalian cells.  
2. Materials and Methods 
2.1. Reagents 
Thapsigargin  (Tg),  Tm,  dimethyl  sulfoxide  (DMSO),  and  RTA  were  purchased  from  
Sigma-Aldrich. Ricin holotoxin was purchased from Vector Labs. DTT was obtained from AnaSpec 
Inc.  Cell  culture  media  were  from  Invitrogen  and  fetal  bovine  serum  was  purchased  from  
Atlanta Biologicals. 
2.2. Cell Culture 
The human cervical cancer cell line HeLa was kindly provided by Dr. Tom Obrig (University of 
Virginia, Charlottesville, VA) and the bovine mammary epithelial cell line MAC-T was established by 
immortalization  with  Simian  virus  40  large  T  antigen  [25].  Both  cell  lines  were  maintained  as 
previously  described  [26].  For  experiments,  cells  were  grown  on  60  mm  tissue  culture  plates  in 
complete media containing serum and grown to confluence, washed twice with phosphate buffered 
saline (PBS) and then changed to serum-free media containing 0.2% bovine serum albumin (BSA) and 
30 nM sodium selenite for 2 h. After the serum-free wash, cells were incubated in serum-free media 
with treatments for various times as indicated in figure legends.  
2.3. Western Blotting 
Cells were lysed for protein analysis as previously described [26]. Total protein concentration was 
measured by Bradford protein assay (Bio-Rad Laboratories). Proteins were separated by SDS-PAGE 
and  transferred  to  0.45  μm  PVDF  membrane  (Millipore)  or  nitrocellulose  membrane  (Bio-Rad). 
Membranes were blocked in tris buffered saline (TBS) with 0.1% Tween-20 (TBST) in 5% skim milk 
for 1 h at room temperature and incubated in primary antibodies overnight at 4 ° C. After incubation, 
the  membranes  were  washed  three  times  with  TBST  for  10  min  each  and  incubated  with  the 
appropriate  secondary  antibody  conjugated  to  horseradish  peroxidase  (anti-rabbit  IgG  from  GE;  
anti-mouse IgG from Vector Labs; anti-goat IgG from Santa Cruz) for 1 h at room temperature and 
then washed three times with TBST. Peroxidase activity was detected by enhanced chemiluminescence 
substrate  (ECL)  from  Pierce.  Total  eIF2α  antibody  was  purchased  from  Santa  Cruz;  p-eIF2α,  
total-IRE1, cleaved caspase 3, and total and cleaved caspase 7 antibodies were obtained from Cell 
Signaling Technology and p-IRE1 antibody was from Novus Biological. Toxins 2011, 3                         
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2.4. RT-PCR Assay to Detect XBP1 Splicing  
Cells  were  lysed  in  Trizol  (Invitrogen)  for  RNA  analysis  according  to  the  manufacturer’s 
recommendations. 
Total RNA was isolated by the Qiagen RNeasy kit. The isolated RNA concentration was measured 
by the NanoDrop™ 1000 Spectrophotometer (Thermo Scientific) and RNA integrity was examined by 
agarose gel electrophoresis. To assess XBP1 splicing, total RNA (2 μg) was reverse transcribed using 
the  High  Capacity  cDNA  Reverse  Transcription  Kit  (Applied  Biosystems).  The  PCR  primers  for 
human cells were forward primer (F): 5' CCT TGT AGT TGA GAA CCA GG 3'; reverse primer (R): 
5'  GGG  GCT  TGG  TAT  ATA  TGT  GG  3'.  The  PCR  primers  for  bovine  cells  were  F:  
5' CCT TGT AGT TGA GAA TCA GG 3'; R: 5' GGG GCT TTG TAT ACG TGA 3'. Primers were 
obtained  from  Sigma-Aldrich.  10X  PCR  gold  buffer,  MgCl2,  dNTP,  and  Ampli-Taq  Gold  were 
purchased from Applied Biosystems. PCR was performed with an initial denaturation step of 95
 ° C for 
10 min, followed by 35 cycles at 95 ° C for 1 min, 50 ° C for 1 min, and 72 ° C for 1 min, and a final 
extension  step  at  72  ° C  for  10  min.  The  amplified  PCR  products  were  separated  by  agarose  gel 
electrophoresis on 3% gels and visualized with ethidium bromide. 
2.5. Quantitative(q) RT-PCR 
Primers used for qRT-PCR are listed in Table 1. Each primer set was validated by generating a 
standard curve from a pool of cDNA with serial dilutions ranging from 1:2 to 1:20,000. The expression 
of target genes in individual samples was measured using an Applied Biosystems 7300 Real-time PCR 
system. A dilution of cDNA ranging from 1:4 to 1:20 depending on the gene was amplified in a total 
reaction volume of 20 μL that included 250 nM forward and reverse primers (5 pmole each) and 10 μL 
of Power SybrGreen PCR MasterMix (Applied Biosystems). For each experimental sample, values 
were  calculated  relative  to  untreated  control  samples  using  the  2
−ΔΔCT  method  with  β-actin  or 
cyclophilin as the housekeeping gene. 
Table 1. Primer design for quantitative RT-PCR. 
Gene  Forward Primer (5' to 3')  Reverse Primer (5' to 3') 
Human spliced XBP-1  TGCTGAGTCCGCAGCAGG  CGCCAGAATCCATGGGGAGA 
Human total XBP-1  GCAAGCGACAGCGCCT  TTTTCAGTTTCCTCCTCAGCG 
Human β-actin  AATGTGGCCGAGGACTTTGATTGC  AGGATGGCAAGGGACTTCCTGTAA 
Bovine spliced XBP-1  TGCTGAGTCCGCAGCAGG  CATCAGAGTCCATGGGGAGA 
Bovine total XBP-1  GCAAGCGACAGCGCCT  TTTTCAGTTTCCTCCGCAGCG 
Bovine cyclophilin  GAGCACTGGACAGAAAGGATTTGG  TGAAGTCACCAGCCTGGCACATAA 
2.6. Protein Synthesis Inhibition 
Confluent  cells  were  serum-starved  for  two  h,  washed  two  times  with  methionine-free  media 
(Invitrogen)  and  incubated  in  methionine-free  media  for  45  min  prior  to  treatment  with  toxin. 
Approximately 8 μCi [
35S] methionine (MP Biomedicals) were added to each sample during the last  
30  min  of  toxin  treatment.  Cells  were  washed  twice  with  cold  PBS  and  scraped  into  cold  5% 
trichloroacetic  acid  (TCA).  Samples  were collected on glass microfiber filters  (Whatman) using a Toxins 2011, 3                         
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vacuum manifold, washed three times with ice-cold 5% TCA and washed two times with cold 95% 
ethanol. ScintiVerse cocktail (Fisher) was added to each sample and radioactivity was determined by 
scintillation counting (Beckman Coulter). 
2.7. Statistical Analysis 
Data were analyzed by one-way ANOVA with Bonferroni’s Multiple Comparison Post-hoc test or 
by student’s paired t-test using GraphPad Prism 5 Software. 
3. Results 
3.1. RTA Inhibits XBP1 Splicing in Mammalian Cells 
XBP1 splicing subsequent to IRE1 phosphorylation is a primary component of the UPR response. 
Therefore  we  first  examined  whether  RTA  would  affect  this  arm of UPR in  the non-transformed 
mammary epithelial cell line MAC-T. We have previously shown that these cells are sensitive to RTA 
in terms of depurination, protein synthesis inhibition, and apoptosis within 4 h of treatment [26]. As 
shown in Figure 1A, only the unspliced form of XBP1 was present in cells treated with RTA (0.1 or 
1.0 µg/mL), indicating that RTA did not affect XBP1 splicing. As expected, treatment with Tm, which 
blocks N-linked glycosylation, caused XBP1 mRNA splicing in MAC-T cells as shown by the decrease 
in the upper unspliced form and appearance of the smaller spliced form of XBP1. Treatment with 0.1 
and 1.0 μg/mL RTA dramatically reversed this effect, with almost complete elimination of the spliced 
XBP1  band  evident  by  gel  electrophoresis.  To  quantify  these  changes,  a  qRT-PCR  assay  was 
established. XBP1 splicing was increased 61- to 99-fold by Tm in the three experiments (data not 
shown). As shown in Figure 1B, RTA treatment inhibited Tm-induced XBP1 splicing by 50 to 87% at 
concentrations of 0.1 and 1.0 μg/mL, respectively. Total (i.e., spliced plus unspliced) XBP1 mRNA 
expression was not different between cells treated with Tm alone and those treated with Tm plus  
0.1 μg/mL RTA while total XBP1 mRNA levels were 50% lower in Tm-treated cells exposed to the 
higher concentration of RTA relative to  cells  treated with  Tm  alone. These data indicate that the 
decrease in XBP1 splicing was not a direct reflection of decreases in unspliced XBP1 mRNA levels. 
To  determine  if  the  holoenzyme  acts  similarly  to  RTA,  experiments  were  repeated  with  ricin 
holotoxin, RTA and RTB. None of these alone stimulated XBP1 splicing. Ricin and RTA produced 
similar inhibition of Tm-induced XBP1 splicing, while RTB had no effect on XBP1 splicing induced 
by Tm (Figure 1C). These concentrations of RTA and ricin inhibited total protein synthesis 82 and 
97%, respectively, while RTB had a negligible effect on protein synthesis inhibition (Figure 1D). 
UPR is also induced by thapsigargin (Tg), which disrupts calcium homeostasis in the ER, as well as 
DTT, which reduces protein disulfide bonds. Therefore, we determined if RTA could inhibit the ability 
of either of these chemicals to induce XBP1 splicing in MAC-T cells. As shown in Figure 2A and B, 
both Tg and DTT induced XBP1 splicing in MAC-T cells, however, RTA alone did not inhibit XBP1 
splicing  by  either  agent.  A  slight  but  significant  decrease  in  total  XBP1  mRNA  expression  was 
observed  with  1  µg/mL  RTA  plus  Tg  compared  to  Tg  alone,  while  RTA  had  no  effect  on  this 
parameter in DTT treated cells (Figure 2B). Toxins 2011, 3                         
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Figure 1. RTA and ricin inhibit tunicamycin (Tm)-induced XBP1 splicing in MAC-T cells. 
(A)  Cells  were  serum-starved  for  2  h  prior  to  treatment  ±   RTA  (0.1  or  1.0  µg/mL)  
and ±  Tm (2.5 µg/mL) for 4 h. Total RNA was analyzed by RT-PCR as described in 
Materials and Methods. U = unspliced XBP1, S = spliced XBP1; (B) qRT-PCR analysis of 
XBP1 expression. Data were corrected for cyclophilin and presented relative to levels in 
cells treated with Tm alone. Data were analyzed by one-way ANOVA with Bonferroni’s 
Multiple Comparison post-hoc test. ** P < 0.001 and * P < 0.01 indicates different from 
Tm-treated cells. Bars represent mean ±  S.E. of four experiments; (C) Cells were treated 
with  0.1  µg/mL  of  RTA  (A),  1  µg/mL  of  RTB  (B)  or  0.01  µg/mL  of  ricin  
holotoxin (R) ±  2.5 µg/mL Tm for 4 h and total RNA was analyze by RT-PCR; (D) Total 
protein  synthesis  was  determined  by  [
35S]methionine  incorporation.  MAC-T  cells  were 
treated with 0.1 µg/mL RTA, 1 µg/mL RTB or 0.01 µg/mL ricin holotoxin for 4 h. Bars 
represent mean ±  SE of 3 experiments.  
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Figure  2.  RTA  does  not  inhibit  thapsigargin  (Tg)  or  DTT-induced  XBP1  splicing  in  
MAC-T  cells.  Cells  were  serum-starved  for  2  h  prior  to  treatment  ±   RTA  (0.1  and  
1.0 µg/mL) and ±  Tg (1 µg/mL) or DTT (2 mM) for 4 h. (A) Total RNA was analyzed by 
RT-PCR.  U  =  unspliced  XBP1;  S  =  spliced  XBP1;  (B)  qRT-PCR  analysis  of  XBP1 
expression. Data were corrected for cyclophilin and presented relative to levels in cells 
treated with Tg or DTT alone. Data were analyzed by one-way ANOVA with Bonferroni’s 
Multiple Comparison post-hoc test. * indicates different from Tg-treated cells (P < 0.05). 
Bars represent mean ±  S.E. of four experiments.  
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Figure 2. Cont. 
 
In order to determine if the inhibition of Tm-induced XBP1 mRNA splicing by RTA was also 
observed  in  transformed  cells,  the  experiments  were  repeated  in  HeLa  cells,  a  human  cervical 
carcinoma cell line, which is also responsive to RTA as shown in our previous work [26]. Similar to 
results obtained with MAC-T cells, RTA alone (1 μg/mL) could not induce XBP-1 mRNA splicing in 
HeLa cells but did inhibit Tm-induced XBP1 splicing (Figure 3A). This represented an inhibition of 
35% when analyzed by qRT-PCR (Figure 3B). The inhibition at 4 h was not due to a decrease in total 
XBP1  mRNA  levels  since  cells  treated  with  RTA  plus  Tm  expressed  more  total  XBP1  mRNA 
compared to cells treated with Tm alone (Figure 3B). In addition, ricin holotoxin induced a similar 
inhibition of Tm-induced XBP1 splicing, while RTB had no effect (Figure 3C). These concentrations 
of  RTA  and  ricin  inhibited  total  protein  synthesis  88  and  95%,  respectively,  while  RTB  had  a 
negligible effect on protein synthesis inhibition (Figure 3D). As was observed for MAC-T cells, XBP1 
splicing was induced by both Tg and DTT, but RTA had no effect on this response (Figure 4A,B). 
Interestingly, RTA together with Tg increased total XBP-1 by 50% (Figure 4B). 
3.2. RTA Inhibits Tm-Induced Phosphorylation of IRE1 
Since RTA inhibited Tm-induced XBP1 mRNA splicing, we looked upstream of XBP1 at IRE1 
phosphorylation. As shown in Figure 5A, Tm, Tg, and DTT each induced IRE1 phosphorylation at 
least 3-fold in HeLa cells. Similar to the results of the XBP1 mRNA splicing assay, RTA alone could 
not  induce  IRE1  phosphorylation.  However,  similar  to  its  ability  to  decrease  Tm-induced  XBP1 
splicing, treatment with 1 μg/mL RTA decreased Tm-induced IRE1 phosphorylation (Figure 5B). RTA 
had  no  effect  on  DTT-  or  Tg-induced  XBP1  splicing.  Similar  studies  could  not  be  conducted  in  
MAC-T cells since IRE1 antibodies did not recognize the bovine proteins. Toxins 2011, 3                         
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Figure 3. RTA and ricin inhibit tunicamycin (Tm)-induced XBP1 splicing in HeLa cells. 
Cells were serum-starved for 2 h then treated ±  RTA (1.0 µg/mL) and ±  Tm (2.5 µg/mL) 
for 4 h. (A) Total RNA was analyzed by RT-PCR. U = unspliced XBP1; S = spliced XBP1; 
(B) qRT-PCR analysis of XBP1 expression corrected for β-actin and presented relative to 
Tm  alone.  Data  were  analyzed  by  one-way  ANOVA  with  Bonferroni’s  Multiple 
Comparison post-hoc test. **P < 0.001 and * P < 0.01 indicates different from Tm-treated 
cells.  Bars  represent  mean  ±   S.E.  of  four  experiments;  (C)  Cells  were  treated  with  
1.0 µg/mL of RTA (A), 1.0 µg/mL of RTB (B) or 0.1 µg/mL of ricin (R) ±  2.5 µg/mL Tm 
for 4 h; (D) Total protein synthesis in cells treated as in (C) for 4 h. Bars represent mean  
±  SE of 3 experiments. 
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Figure  4.  RTA  does  not  affect  thapsigargin  (Tg)-  and  DTT-induced  XBP1  splicing  in  
HeLa  cells.  Cells  were  serum-starved  for  2  h  prior  to  treatment  ±   RTA  (1.0  µ g/mL)  
and ±  Tg (1.0 µ g/mL) for 4 h or ±  RTA (1.0 µ g/mL) for 4 h and ± DTT (2 mM) added over 
the last 30 min of treatment. (A)  Total RNA was analyzed by RT-PCR as described in 
Materials and Methods. U = unspliced XBP1; S = spliced XBP1; (B, C) qRT-PCR analysis of 
XBP1 expression. Data were corrected for β-actin and presented relative to levels in cells 
treated with Tg or DTT alone. Data were analyzed by paired two-tailed t-test. * P < 0.05 
indicates different from Tg-treated cells. Bars represent mean ±  S.E. of four experiments. 
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Figure 5. RTA inhibits tunicamycin (Tm)-induced phosphorylation of IRE1 in HeLa cells. 
Cells were serum-starved for 2 h prior to treatment with RTA (1 μg/mL) ±  Tm (2.5 μg/mL) 
or Tg (1 μg/mL) for 4 h or with RTA (1 μg/mL) for 4 h with DTT (2 mM) added over the 
last 30 min of treatment. Cell lysates (50 μg) were analyzed by SDS-PAGE. Membranes 
were  immunoblotted  with  phospho-IRE1  antibody  then  stripped  and  reprobed  for  total 
IRE1. A representative blot is shown in panel A; (B) Data were analyzed by densitometry. 
Phospho-IRE1 was corrected for loading using total IRE1. Bars represent mean ±  S.E. of  
5 experiments. Data were analyzed by paired two-tailed t-test. * P < 0.05 indicates different 
from Tm alone.  
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3.3. RTA Inhibits DTT-Induced Phosphorylation of eIF2α 
PERK, another arm of UPR, shares a similar activation mechanism during induction of ER stress. 
To determine if the PERK pathway was affected by RTA, western blotting of phospho-eIF2α was 
performed. eIF2α is a direct substrate of phospho-PERK, the activated form of PERK. As expected, 
phosphorylation of eIF2α in HeLa cells was induced 2- to 4-fold compared to untreated controls by 
exposure to Tm, Tg or DTT (Figure 6A). RTA alone could not induce eIF2α phosphorylation. When 
HeLa cells  were treated with these UPR-inducing reagents in the presence of RTA, DTT-induced 
eIF2α phosphorylation was dramatically inhibited by approximately 80% relative to cells treated with 
DTT  alone  (Figure  6A,B).  However,  RTA  could  not  inhibit  Tm-  and  Tg-induced  eIF2α 
phosphorylation (Figure 6C,D).  
3.4. Inhibition of ER Stress by RTA Differentially Affects Protein Synthesis Inhibition in MAC-T and 
HeLa Cells  
Protein synthesis inhibition is often used as a marker of ricin-induced cytotoxicity. To determine if 
inhibition of UPR by RTA affected this parameter, de novo protein synthesis was measured after 4 h of 
RTA treatment  (Figure 7). MAC-T cells  were very sensitive to  Tm  and DTT in terms of protein 
synthesis inhibition, with decreases of 39 and 65%, respectively, relative to untreated controls. Cells 
were less sensitive to Tg, which inhibited protein synthesis less than 20%. When MAC-T cells were 
treated with  Tm  or DTT together with  RTA, inhibition  of protein synthesis was greater than that Toxins 2011, 3                         
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observed with either agent alone at all three concentrations of RTA examined. Interestingly, when cells 
were treated with RTA together with Tg, the ability of RTA to inhibit protein synthesis was reduced. In 
contrast to MAC-T cells, all three UPR-inducing agents decreased protein synthesis approximately 
80% in HeLa cells. Overall, RTA had a similar effect on protein synthesis inhibition with or without 
Tm or DTT. Similar to MAC-T cells, Tg attenuated the ability of RTA to inhibit protein synthesis in 
HeLa cells. 
Figure 6. RTA inhibits DTT-induced phosphorylation of eIF2α in HeLa cells. Cells were 
serum-starved  for  2  h  prior  to  treatment  with  RTA  (1  μg/mL)  ±   Tm  (2.5  μg/mL)  or  
Tg (1 μg/mL) for 4 h or with RTA (1 μg/mL) for 4 h with DTT (2 mM) added over the last 
30 min of treatment. Total cell lysates (50 μg) were analyzed by SDS-PAGE. Membranes 
were  immunoblotted  with  phospho-eIF2α  antibody  then  for  total  eIF2α  protein.  
(A)  Representative  blot  is  shown;  (B)  Data  were  quantified  by  densitometry.  
Phospho-eIF2-α was corrected for loading using total eIF2-α. Bars represent mean ± S.E. of 
3 experiments. * P < 0.01 indicates different from DTT alone by paired two-tailed t-test. 
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Figure 7. Inhibition of protein synthesis is enhanced in cells treated with both RTA and 
UPR-inducing agents in MAC-T cells but not in HeLa cells. MAC-T or HeLa cells were 
serum-starved for 2 h prior to treatment with RTA and Tm (2.5 μg/mL), Tg (1 μg/mL) or 
DTT  (2  mM)  for  4  h  with  the  exception  that  for  HeLa  cells,  DTT  was  added  over  
the last 30 min of treatment. Total protein synthesis was determined by [
35S]methionine 
incorporation. Bars represent mean ±  SE of 3 experiments. 
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3.5. Inhibition of ER Stress Sensitizes Cells to RTA-Induced Caspase Activation 
Activation  of  the  UPR  pathway  represents  a  survival  response  that  allows  the  cell  to  recover 
homeostasis after an ER overload. Since RTA inhibited the IRE1 pathway induced by Tm and the 
PERK pathway induced by DTT, we were interested in determining if RTA would activate caspases to 
a greater degree  in  the absence of the UPR-survival pathway. As shown in Figure 8, cleavage of 
caspase-3 and -7 was observed in both MAC-T and HeLa cells treated with RTA. No cleavage was 
evident when cells were treated with UPR-inducing reagents alone. However, when cells were treated 
with Tm and DTT in combination with RTA, caspase cleavage was augmented. In contrast, Tg had no 
effect on caspase cleavage by RTA. These data indicate inhibition of UPR by RTA could make cells 
more vulnerable to cell death.  
Figure 8. Caspase cleavage is enhanced in cells treated with both RTA and UPR-inducing 
agents compared to either alone. (A) MAC-T cells were serum-starved for 2 h prior to 
treatment with RTA and Tm (2.5 μg/mL), Tg (1 μg/mL) or DTT (2 mM) for 4 h; (B) HeLa 
cells were serum-starved for 2 h prior to treatment with RTA and Tm (2.5 μg/mL) or  
Tg (1 μg/mL) for 4 h or RTA for 4 h with DTT (2 mM) added over the last 30 min  
of treatment. Total cell lysates (30 μg for MAC-T and 50 μg for HeLa) were separated  
by  15%  SDS-PAGE  and  immunoblotted  with  cleaved  caspase-3,  total  and  cleaved  
caspase-7 antibodies. 
 
 
4. Discussion 
A wide variety of stressors including nutrient deprivation, disruption of calcium homeostasis and 
hypoxia activate ER stress and elicit the UPR [27–29]. RTA unfolds in the ER, causing the cell to 
perceive it as a misfolded protein that should be targeted to the ER-associated degradation pathway 
(ERAD)  [30].  Therefore,  RTA  could  potentially  activate  the  UPR,  which  could  contribute  to  its 
apoptotic effects. However, results of the present study found that RTA alone failed to activate either 
the IRE1/XBP1 arm or the PERK/eIF2-α branch of the UPR pathway. This agrees with studies in yeast, 
which also found that RTA alone did not affect HAC1 mRNA splicing, the yeast homologue of XBP1 
and the only branch of the UPR pathway that exists in yeast [24]. In contrast with these data, ricin and 
the RIP riproximin were recently reported to inhibit eIF2-α phosphorylation and to decrease intact Toxins 2011, 3                         
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ATF-6 protein in two human cancer cell lines, MCF-7 and HCT-11, indicating that these two UPR 
pathways  were  induced  by  toxin  treatment  [22].  However,  similar  to  the  present  findings,  these 
investigators also found no XBP-1 splicing in response to toxin exposure. Both of these effects on 
UPR were observed after 24 h of treatment, in contrast to the present study where cells were treated for 
only 4 h. Therefore, this may reflect a difference in sensitivity to toxins between different cell types. 
Interestingly, Shiga toxin, which shares a similar retrograde transport pathway with RTA, has been 
reported  to  induce  all  three  branches  of  the  UPR  in  the  human  myelogenous  leukemia  cell  line  
THP-1 [23]. 
RTA inhibits Tm-induced HAC1 mRNA splicing in yeast [24]. Therefore we investigated whether 
RTA would have a similar effect on XBP1 splicing in response to ER stress in mammalian cells. We 
have previously reported that RTA induces apoptosis in both HeLa and MAC-T cells, which represent 
transformed and non-transformed epithelial cell lines, respectively [26]. RTA inhibited XBP1 mRNA 
splicing induced by Tm in both cell lines. Since XBP1 splicing is induced by activation of the signaling 
molecule IRE1 [31,32], we investigated IRE1 phosphorylation and found that RTA also inhibited IRE1 
autophosphorylation induced by Tm in HeLa cells. Interestingly, RTA did not inhibit XBP1 splicing or 
IRE1 phosphorylation induced by DTT or Tg. The ability of RTA to inhibit induction of the PERK arm 
of UPR, as evidenced by a decrease in eIF2-α phosphorylation, also differed depending on which  
UPR-inducing agent was used. The explanation for this is unclear, but could relate to different actions 
of Tm and DTT that result from inhibiting glycosylation versus disulfide bond formation, respectively. 
In addition, RTA did not inhibit any UPR parameter induced by Tg. During UPR, the accumulation of 
unfolded proteins in the ER lumen causes the chaperone protein BiP to dissociate from ER-membrane-
associated IRE1 and PERK, allowing these molecules to oligomerize and autophosphorylate [33,34]. 
Therefore, one potential mechanism by which RTA could inhibit phosphorylation would be to reduce 
general protein synthesis so that BiP fails to dissociate from IRE1 and PERK, which would prevent 
their  activation.  However,  if  this  were  the  mechanism,  RTA  would  be  expected  to  inhibit  both 
signaling pathways in response to Tm and DTT, as well as Tg. The findings that different branches of 
UPR  were  inhibited  by  RTA  in  Tm-induced  ER  stress  compared  to  DTT  and  that  no  effect  was 
observed on Tg-induced UPR signaling suggest that RTA is not using a general mechanism involving 
protein synthesis inhibition to inhibit UPR.  
When expressed in yeast, both pre-RTA, which contains the ER localization sequence, and mature 
RTA, which lacks this sequence and thus fails to enter the ER, inhibit Tm-induced UPR [24]. Based on 
these data, the authors suggested that RTA inhibits UPR from the cytosolic side of the ER and not the 
luminal side. Translocation of proteins across the ER membrane requires chaperone proteins, such as 
BiP  and  calnexin,  which  are  calcium-dependent  [35]  and  calcium  depletion  decreases  RTA 
translocation and toxicity in mammalian cells [8]. Therefore, a possible explanation for the failure of 
RTA to inhibit Tg-induced phosphorylation of IRE1 and/or eIF2-α is that retrotranslocation of RTA 
from the ER to the cytosol is decreased due to the disruption in ER calcium concentration by Tg. This 
explanation  is  supported  by  the  finding  that  the  ability  of  RTA  to  inhibit  protein  synthesis  was 
dramatically reduced in the presence of Tg in both cell lines (Figure 7). These data provide additional 
support for the idea that the inhibition of UPR by RTA occurs on the cytosolic side of the ER. Toxins 2011, 3                         
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When  MAC-T  cells  were  treated  with  Tm  or  DTT  together  with  RTA,  protein  synthesis  was 
inhibited to a greater degree that it was with RTA alone, indicating that the two agents are more 
cytotoxic in combination. Since Tm and DTT each inhibited protein synthesis on their own, this could 
be an additive effect. Interestingly, in HeLa cells where Tm and DTT had minimal effects on protein 
synthesis,  the  addition  of  either  UPR-inducing  agent  did  not  alter  RTA-induced  protein  synthesis 
inhibition. Since UPR is a survival response that pushes the cell toward apoptosis if homeostasis is not 
restored, we asked the question of whether or not inhibiting the UPR could alter RTA-induced caspase 
activation as a marker for apoptosis. Treatment of HeLa cells with RTA in combination with Tm or 
DTT evoked greater caspase cleavage than that observed in response to RTA, Tm, or DTT alone while 
the ability of RTA to inhibit protein synthesis when UPR was inhibited was not altered. These data 
indicate  that  inhibiting  the  UPR  allows  RTA  to  increase  cell  death  through  a  mechanism  that  is 
independent  of  protein  synthesis  inhibition.  This  supports  previous  findings  in  yeast  using  RTA 
mutants which show that protein synthesis inhibition and cell death can be uncoupled [15]. RTA has 
been investigated as  the toxic component of  an immunotoxin  that could  specifically target cancer  
cells  [2,3,36].  The  UPR  is  activated  by  hypoxia  in  solid  tumors,  resulting  in  resistance  to  
chemotherapy [37]. Similarly, increases in spliced XBP1 relative to unspliced XBP1 have been shown 
to correlate with poor prognosis in breast cancer [38] and XBP1 has been proposed as a therapeutic 
target for solid tumors [39]. Therefore, the ability of RTA to inhibit UPR may make it more potent as a 
targeted therapy for cancer. This may be particularly useful in cancer cells where UPR is already 
upregulated by conditions such as hypoxia. 
5. Conclusions 
The  present  work  shows  that  RTA  can  inhibit  ER  stress,  leading  to  an  enhancement  of  its 
cytotoxicity. ER stress has been shown to be an important component of several disease conditions, 
including cancer [40]. The ability of RTA to enhance its own cytotoxicity by inhibiting UPR represents 
a novel mode of action that may enhance its potential as a therapeutic agent in solid tumors. 
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